Новые панкреатические гормоны: грелин (обзор литературы)

1. Васюкова О.В., Витебская А.В. Грелин: биологическое значение и перспективы применения в эндокринологии // Пробл. эндокринол. — 2006. — № 2. — С. 3—7.
2. Верин В.К., Иванов В.В. Гормоны и их эффекты: справочник. — СПб.: Фолиант, 2011. — 136 с.
3. Орлова Е.Г., Ширшев С.В. Регуляция лептином и грелином экспрессии мембранных молекул и апоптоза лимфоцитов человека при беременности // Пробл. эндокринол. — 2010. — № 3. — С. 26—30.
4. Островки Лангерганса / [Электронный ресурс]. — Режим доступа: URL: mmorpgbb.ru›foegwoeg/ (дата обращения: 12.07.2013).
5. Панков Ю.А. Революционные перемены в эндокринологии // Пробл. эндокринол. — 2005. — № 6. — С. 3—8.
6. Терещенко И.В., Каюшев П.Е. Грелин и его роль в норме и патологии // Тер. арх. — 2013. — № 4. — С. 98—101.
7. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic β-cells and human islets: involvement of 3′,5′-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling / R. Granata, F. Settanni, L. Biancone [et al.] // Endocrinol. — 2007. — V. 148. — P. 512—529.
8. Adeghate E., Ponery A.S. Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats // J. Neuroendocrinol. — 2002. — V. 14. — P. 555—560.
9. Antioxidant enzyme activity and MDA level in the rat testis following chronic administration of ghrelin / A. Kheradmand, M. Alirezaei, P. Asadian [et al.] // Androl. — 2009. — V. 41, N. 6. — P. 335—340.
10. A preprandial rise in plasma ghrelin levels suggests a role in mealinitiation in humans / D.E. Cummings, J.Q. Purnell, R.S. Frayo [et al.] // Diabetes. — 2001. — V. 50. — P. 1714—1719.
11. A role for ghrelin in the central regulation of feeding / M. Nakazato, N. Murakami, Y. Date [et al.] // Nature. — 2001. — V. 409. — P. 194—198.
12. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin / F.J. van der Lely, M. Tschop, M.L. Heiman [et al.] // Endocr. Rev. — 2004. — V. 25. — P. 426—457.
13. Cellular location and hormonal regulation of ghrelin expression in rat testis / M.L. Barreiro, F. Gaytan, J.E. Caminos [et al.] // Biol. Reprod. — 2002. — V. 67. — P. 1768—1776.
14. Circulation Ghrelin in patients undergoing elective cholecystectomy / C. Chiesa, J.F. Osborn, L. Pacifico [et al.] // Clin. Chem. — 2005. — V. 51, N. 7. — P. 1258—1261.
15. Cummings D.E., Foster-Schubert K.E., Overduin J. Ghrelin and energy balance: focus on current controversies // Curr. Drug. Targets. — 2005. — V. 6. — P. 153—169.
16. Dezaki К. Ghrelin function in insulin release and glucose metabolism // The Ghrelin System / A. Benso, F.F. Casanueva, E. Ghigo [et al.] (eds.). — Basel: Karger, 2013. — V. 25 Endocrine Development. — P. 135—143.
17. Dezaki K., Sone H., Yada T. Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis // Pharmacol. Therapeutics. — 2008. — V. 118. — P. 239—249.
18. Differential responses of circulating ghrelin to high-fat or high-carbohydrate meal in healthy women / P. Monteleone, R. Bencivenga, N. Longobardi [et al.] // J. Clin. Endocrinol. Metab. — 2003. — V. 88, N. 11. — P. 5510—5514.
19. Dimaraki E.V. Jaffe C.A. Role of endogenous ghrelin in growth hormone secretion, appetite regulation and metabolism // Rev. Endocrin. Metab. Dis. — 2006. — V. 7, N. 4. — P. 237—249.
20. Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart / S. Frascarelli, S. Ghelardoni, S. Ronca-Testoni [et al.] // Bas. Res. Cardiol. — 2003. — V. 98, N. 6. — P. 401—405.
21. Effects of ghrelin and other neuropeptides (CART, MCH, Orexin A and B, and GLP-1) on the release of insulin from isolated rat islets / M. Colombo, S. Gregersen, J. Xiao [et al.] // Pancreas. — 2003. — V. 27. — P. 161—166.
22. Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice / A. Salehi, C. Dornonville de la Cour, R. Hakanson [et al.] // Regul. Pept. — 2004. — V. 118. — P. 143—150.
23. Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans / F. Broglio, C. Gottero, A. Benso [et al.] // J. Clin. Endocrinol. Metab. — 2003. — V. 88. — P. 4268—4272.
24. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone / E. Arvat, M. Maccario, L. Di Vito [et al.] // J. Clin. Endocrinol. Metab. — 2001. — V. 86. — P. 1169—1174.
25. Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in β-cells: implication in the glycemic control in rodents / K. Dezaki, H. Hosoda, M. Kakei [et al.] // Diabetes. — 2004. — V. 53. — P. 3142—3151.
26. Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways / T. Wasseem, M. Duxbury, H. Ito [et al.] // Surgery. — 2008. — V. 143. — P. 334—342.
27. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors / M. Volante, E. Allia, P. Gugliotta [et al.] // J. Clin. Endocrinol. Metab. — 2002. — V. 87. — P. 1300—1308.
28. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T-cells, B-cells, and neutrophils / N. Hattori, T. Saito, T. Yagyu [et al.] // J. Clin. Endocrinol. Metab. — 2001. — V. 86. — P. 4284—4291.
29. Ghrelin activates neuronal constitutive nitric oxide synthase in pancreatic islet cells while inhibiting insulin release and stimulating glucagon release / S.S. Qader, I. Lundquist, M. Ekelund [et al.] // Regul. Pept. — 2005. — V. 128. — P. 51—56.
30. Ghrelin — a hormone with multiple functions / M. Korbonits, A.P. Goldstone, M. Gueorguiev // Front. Neuroendocrinol. — 2004. — V. 25, N. 1. — P. 27—68.
31. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans / F. Broglio, E. Arvat, A. Benso [et al.] // J. Clin. Endocrinol. Metab. — 2001. — V. 86. — 5083—5086.
32. Ghrelin and desacyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT / G. Baldanzi, N. Filigheddu, S. Cutrupi [et al.] // J. Cell. Biol. — 2002. — V. 159. — 1029—1037.
33. Ghrelin and its relationship to growth hormones during normal pregnancy / J. Fuglsang, C. Skjaebaek, U. Espelund [et al.] // Clin. Endocrinol. (Oxf.). — 2005. — V. 62, N. 5. — 554—559.
34. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations / H.M. Lee, G. Wang, E.W. Englander [et al.] // Endocrinol. — 2002. — V. 143. — P. 185—190.
35. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans / Y. Date, M. Kojima, H. Hosoda [et al.] // Endocrinol. — 2000. — V. 141. — P. 4255—4261.
36. Ghrelin, a novel placental-derived hormone / O. Gualillo, J. Caminos, M. Blanco [et al.] // Endocrinol. — 2001. — V. 142. — P. 788—794.
37. Ghrelin, a widespread hormone: insights into molecular and cellular regulation of its expression and mechanism of action / O. Gualillo, F. Lago, J. Gómez-Reino [et al.] // FEBS Letters. — 2003. — V. 552, N. 2—3. — P. 105—109.
38. Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development / C.L. Prado, A.E. Pugh-Bernard, L. Elghazi [et al.] // Proc. Natl. Acad. Sci. USA. — 2004. — V. 101. — P. 2924—2929.
39. Ghrelin directly stimulates glucagon secretion from pancreatic α-cells / J.C. Chuang, I. Sakata, D. Kohno [et al.] // Mol. Endocrinol. — 2011. — V. 25. — P. 1600—1611.
40. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor / M. Kojima, H. Hosoda, H. Matsuo [et al.] // Trends Endocrinol. Metab. — 2001. — V. 12. — P. 118—122.
41. Ghrelin improves endothelial function in patients with metabolic syndrome / M. Tesauro, F. Schinzari, M. Iantorno [et al.] // Circulation. — 2005. — V. 112, N. 19. — P. 2986—2992.
42. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells / V.D. Dixit, E.M. Schaffer, R.S. Pyle [et al.] // J. Clin. Invest. — 2004. — V. 114, N. 1. — P. 57—66.
43. Ghrelin is a growth-hormone-releasing acylated peptide from stomach /M. Kojima, H. Hosoda, Y. Date [et al.] // Nature. — 1999. — V. 402. — P. 656—660.
44. Ghrelin is expressed in a novel endocrine cell type in developing rat islets and inhibits insulin secretion from INS-1 (832/13) cells / N. Wierup, S. Yang, R.J. McEvilly [et al.] // J. Hystochem. Cytochem. — 2004. — V. 52, N. 3. — P. 301—310.
45. Ghrelin is present in pancreatic α-cells of humans and rats and stimulates insulin secretion / Y. Date, M. Nakazato, S. Hashiguchi [et al.] // Diabetes. — 2002. — V. 51. — P. 124—129.
46. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells / M. Murata, Y. Okimura, K. Iida [et al.] // J. Biol. Chem. — 2002. — V. 277. — P. 5667—5674.
47. Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat / L. Trudel, C. Tomasetto, M.C. Rio [et al.] // Am. J. Physiol. Gastrointest. Liver Physiol. — 2002. — V. 282. — P. G948—G952.
48. Ghrelin-producing epsilon cells in the developing and adult human pancreas / K.M. Andralojc, A. Mercalli, K.W. Nowak [et al.] // Diabetol. — 2009. — V. 52, Is. 3. — P. 486—493.
49. Ghrelin stimulates gastric acid secretion and motility in rats / Y. Masuda, T. Tanaka, M. Inomata [et al.] // Biochem. Biophys. Res. Commun. — 2000. — V. 276. — P. 905—908.
50. Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells / C. Dornonville De La Cour, E. Lindstrom, P. Norlen [et al.] // Regul. Pept. — 2004. — V. 120 — P. 23—32.
51. Ghrelin strongly stimulates growth hormone release in humans / K. Takaya, H. Ariyasu, N. Kanamoto [et al.] // J. Clin. Endocrinol. Metab. — 2000. — V. 85. — P. 4908—4911.
52. Ghrelin tissue distribution: comparison between gene and protein expression / S. Ghelardoni, V. Carnicelli, S. Frascarelli [et al.] // J. Endocrinol. Invest. — 2006. — V. 29, N. 2. — P. 115—121.
53. Granata R., Ghigo E. Products of the ghrelin gene, the pancreatic β-cell and the adipocyte // The Ghrelin System / A. Benso, F.F. Casanueva, E. Ghigo [et al.] (eds.). — Basel: Karger, 2013. — V. 25 Endocrine Development. — P. 144—156.
54. Growth hormone secretagogue binding sites in peripheral human tissues / M. Papotti, C. Ghè, P. Cassoni [et al.] // J. Clin. Endocrinol. Metab. — 2000. — V. 85. — P. 3803—3807.
55. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers / N. Nagaya, M. Kojima, M. Uematsu [et al.] // Am. J. Physiol. Regul. Integr. Physiol. — 2001. — V. 280, N. 5. — P. 1483—1487.
56. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure / N. Nagaya, K. Miyatake, V.J. Uematsu [et al.] // J. Clin. Endocrinol. Metab. — 2001. — V. 86. — P. 5854—5859.
57. Heppner K.M., Tong J. Mechanisms in endocrinology: regulation of glucose metabolism by the ghrelin system: multiple players and multiple actions // Eur. J. Endocrinol. — 2014. — V. 171, N. 1. — P. R21— R32.
58. Hosoda H., Kojima M., Kangawa K. Ghrelin and the regulation of food intake and energy balance // Mol. Intervent. — 2002. — V. 2, N. 8. — P. 494—503.
59. Hyperphagic effects of brainstem ghrelin administration / L.F. Faulconbridge, D.E. Cummings, J.M. Kaplan [et al.] // Diabetes. — 2003. — V. 52. — P. 2260—2265.
60. Impact of adiponectin and ghrelin on incident glucose intolerance and on weight change / N.R. Bennett, M.S. Boyne, R.S. Cooper [et al.] // Clin. Endocrinol. — 2009. — V. 70, N. 3. — P. 408—414.
61. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion / E.M. Egido, J. Rodriguez-Gallardo, R.A. Silvestre [et al.] // Eur. J. Endocrinol. — 2002. — V. 146, N. 2. — P. 241—244.
62. Insulin is required for prandial ghrelin suppression in humans / G. Murdolo, P. Lucidi, C.Di Loreto [et al.] // Diabetes. — 2003. — V. 52, N. 12. — P. 2923—2927.
63. Insulin regulates plasma ghrelin concentration / M.F. Saad, B. Bernaba,
C.-M. Hwu [et al.] // J. Clin. Endocrinol. Metab. — 2002. — V. 87. — P. 3997—4000.
64. Isgaard J. Ghrelin and the cardiovascular system // The Ghrelin System / A. Benso, F.F. Casanueva, E. Ghigo [et al.] (eds.). — Basel: Karger, 2013. — V. 25 Endocrine Development. — P. 83—90.
65. Isgaard J., Granata R. Ghrelin in cardiovascular disease and atherogenesis // Mol. Cell. Endocrinol. — 2011. — V. 340, N. 1. — P. 59—64.
66. Kidney produces a novel acylated peptide, ghrelin / K. Mori, A. Yoshimoto, K. Takaya [et al.] // FEBS Lett. — 2000. — V. 486, N. 3. — P. 213—216.
67. Kojima М., Kangawa К. Ghrelin discovery: a decade after // The Ghrelin System / A. Benso, F.F. Casanueva, E. Ghigo [et al.] (eds.). — Basel: Karger, 2013. — V. 25 Endocrine Development. — P. 1—4.
68. Kojima M., Kangawa K. Ghrelin: structure and function // Physiol. Rev. — 2005. — V. 85, N. 2. — P. 495—522.
69. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes / S.M. Pöykkö, E. Kellokoski, S. Hörkkö [et al.] // Diabetes. — 2003. — V. 52, N. 10. — P. 2546—2553.
70. Low serum levels of ghrelin are assosiated with gallstone disease / N. Mendes-Sanches, G. Ponciano-Rodrigues, L. Bermegjo-Martines [et al.] // World J. Gastroenterol. — 2006. — V. 12, N. 19. — P. 3096—3100.
71. Meier U., Gressner A.M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin // Clin. Chem. — 2004. — V. 50. — P. 1511—1525.
72. Metabolic and cardiovascular effects of ghrelin / M. Tesauro, F. Schinzari, M. Caramanti [et al.] // Inter. J. Pept. — 2010. — V. 2010, Art. ID 864342. — 7 P. / [Электронный ресурс]. — Режим доступа: URL: http://dx.doi.org/10.1155/2010/864342 (дата обращения: 12.10.2014).
73. Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release / S. Park, H. Jiang, H. Zhang [et al.] // PNAS. — 2012. — V. 109. — P. 19003—19008.
74. Morphological analysis of ghrelin and its receptor distribution in the rat pancreas / H. Kageyama, H. Funahashi, M. Hirayama [et al.] // Regul. Pept. — 2005. — V. 126. — P. 67—71.
75. Nagaya N., Kangawa K. Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure // Regul. Pept. — 2003. — V. 114. — P. 71—77.
76. Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2 cardiomyocyte cell proliferation / I. Pettersson, G. Muccioli, R. Granata [et al.] // J. Endocrinol. — 2002. — V. 175. — P. 201—209.
77. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity / G. Muccioli, M. Tshop, M. Papotti [et al.] // Eur. J. Pharmacol. — 2002. — V. 440. — P. 235—254.
78. Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men / J. Liu, C.E. Prudom, R. Nass [et al.] // J. Clin. Endocrinol. Metab. — 2008. — V. 93. — P. 1980—1987.
79. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion / T. Shiiya, M. Nakazato, M. Mizuta, [et al.] // J. Clin. Endocrinol. Metab. — 2002. — V. 87, N. 1. — P. 240—244.
80. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin? / S. Soule, C. Pemberton, P. Hunt [et al.] // Clin. Endocrinol. (Oxf.). — 2005. — V. 63. — P. 412—417.
81. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas / S.S. Qader, R. Hakanson, J.F Rehfeld [et al.] // Regul. Pept. — 2008. — V. 146. — P. 230—237.
82. Reimer M.K., Pacini G., Ahren B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse // Endocrinol. — 2003. — V. 144. — P. 916—921.
83. Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels / M. Arosio, C.L. Ronchi, C. Gebbia [et al.] // J. Clin. Endocrinol. Metab. — 2003. — V. 88. — P. 701—704.
84. Structure, regulation and function of ghrelin / T. Sato,†Y. Nakamura, Y. Shiimura [et al.] // J. Biochem. — 2012. — V. 151, Is. 2. — P. 119—128.
85. Tena-Sempere M. Roles of ghrelin and leptin in the control of reproductive Function // Neuroendocrinol. — 2007. — V. 86. — P. 229—241.
86. The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas / N. Wierup, H. Svensson, H. Mulder [et al.] // Regul. Pept. — 2002. — V. 10. — P. 763—769.
87. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion / A.M. Wren, C.J. Small, H.L. Ward [et al.] // Endocrinol. — 2000. — V. 141. — P. 4325—4328.
88. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans / S. Gnanapavan, B. Kola, S.A. Bustin [et al.] // J. Clin. Endocrinol. Metab. — 2002. — V. 87. — P. 2988—2991.
89. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function / O. Cabrera, D.M. Berman, N.S. Kenyon [et al.] // Proc. Natl. Acad. Sci. USA. — 2006. — V. 103. — P. 2334—2339.
90. Thorens B. Brain glucose sensing and neural regulation of insulin and glucagon secretion // Diabetes Obesity Metab. — 2011. — V. 13. — P. 82—88.
91. Tschop M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents // Nature. — 2000. — V. 407. — P. 908—913.
92. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach / E.L. Okumura, N. Nagaya, M. Enomoto [et al.] // J. Cardiovasc. Pharmacol. — 2002. — V. 39, N. 6. — P. 779—783.
93. Wierup N., Sundler F., Heller R.S. The islet ghrelin cell // J. Mol. Endocrinol. — 2014. — V. 52, N. 1. — P. R35—R49.
94. Wu J.T., Kral J.G. Ghrelin: integrative neuroendocrine peptide in health and disease // Ann. Surg. — 2004. — V. 239. — P. 464—474.

1. Vasiukova O.V., Vitebskaia A.V. Ghrelin: biological significance and application prospects in endocrinology. Probl. endokrinol. [Problems of endocrinology], 2006, no. 2, pp. 3—7 (In Russian).
2. Verin V.K., Ivanov V.V. Hormones and their effects. St. Petersburg, Foliant Publ., 2011. 136 p. (In Russian).
3. Orlova E.G., Shirshev S.V. Regulation of leptin and ghrelin expression of membrane molecules and apoptosis in pregnant human’s lymphocytes. Probl. endokrinol. [Problems of endocrinology], 2010, no. 3, pp. 26—30 (In Russian).
4. The islets of Langerhans. Available at: mmorpgbb.ru›foegwoeg/ (accessed: 12 July 2013).
5. Pankov Iu.A. Revolutionary changes in endocrinology. Probl. endokrinol. [Problems of endocrinology], 2005, no. 6, pp. 3—8 (In Russian).
6. Tereshchenko I.V., Kaiushev P.E. Ghrelin and his role in health and disease. Ter. arkh. [Therapeutic archives], 2013, no. 4, pp. 98—101 (In Russian).
7. Granata R., Settanni F., Biancone L. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic β-cells and human islets: involvement of 3′,5′-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase. Akt signaling. Endocrinol., 2007, vol. 148, pp. 512—529.
8. Adeghate E., Ponery A.S. Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats. J. Neuroendocrinol., 2002, vol. 14, pp. 555—560.
9. Kheradmand A., Alirezaei M., Asadian P. Antioxidant enzyme activity and MDA level in the rat testis following chronic administration of ghrelin. Androl., 2009, vol. 41, no. 6, pp. 335—340.
10. Cummings D.E., Purnell J.Q., Frayo R.S. A preprandial rise in plasma ghrelin levels suggests a role in mealinitiation in humans. Diabetes, 2001, vol. 50, pp. 1714—1719.
11. Nakazato M., Murakami N., Date Y. A role for ghrelin in the central regulation of feeding. Nature, 2001, vol. 409, pp. 194—198.
12. Lely van der F.J., Tschop M., Heiman M.L. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev., 2004, vol. 25, pp. 426—457.
13. Barreiro M.L., Gaytan F., Caminos J.E. Cellular location and hormonal regulation of ghrelin expression in rat testis. Biol. Reprod., 2002, vol. 67, pp. 1768—1776.
14. Chiesa C., Osborn J.F., Pacifico L. Circulation Ghrelin in patients undergoing elective cholecystectomy. Clin. Chem., 2005, vol. 51, no. 7, pp. 1258—1261.
15. Cummings D.E., Foster-Schubert K.E., Overduin J. Ghrelin and energy balance: focus on current controversies. Curr. Drug. Targets, 2005, vol. 6, pp. 153—169.
16. Dezaki К. Ghrelin function in insulin release and glucose metabolism. The Ghrelin System. Basel, Karger, 2013, vol. 25, Endocrine Development , pp. 135—143.
17. Dezaki K., Sone H., Yada T. Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis. Pharmacol. Therapeutics, 2008, vol. 118, pp. 239—249.
18. Monteleone P., Bencivenga R., Longobardi N. Differential responses of circulating ghrelin to high-fat or high-carbohydrate meal in healthy women. J. Clin. Endocrinol. Metab., 2003, vol. 88, no. 11, pp. 5510—5514.
19. Dimaraki E.V. Jaffe C.A. Role of endogenous ghrelin in growth hormone secretion, appetite regulation and metabolism. Rev. Endocrin. Metab. Dis., 2006, vol. 7, no. 4, pp. 237—249.
20. Frascarelli S., Ghelardoni S., Ronca-Testoni S. Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart. Bas. Res. Cardiol., 2003, vol. 98, no. 6, pp. 401—405.
21. Colombo M., Gregersen S., Xiao J. Effects of ghrelin and other neuropeptides (CART, MCH, Orexin A and B, and GLP-1) on the release of insulin from isolated rat islets. Pancreas, 2003, vol. 27, pp. 161—166.
22. Salehi A., Dornonville de la Cour C., Hakanson R. Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice. Regul. Pept., 2004, vol. 118, pp. 143—150.
23. Broglio F., Gottero C., Benso A. Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans. J. Clin. Endocrinol. Metab., 2003, vol. 88, pp. 4268—4272.
24. Arvat E., Maccario M., Di Vito L. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J. Clin. Endocrinol. Metab., 2001, vol. 86, pp. 1169—1174.
25. Dezaki K., Hosoda H., Kakei M. Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in β-cells: implication in the glycemic control in rodents. Diabetes, 2004, vol. 53, pp. 3142—3151.
26. Wasseem T., Duxbury M., Ito H. Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery, 2008, vol. 143, pp. 334—342.
27. Volante M., Allia E., Gugliotta P. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J. Clin. Endocrinol. Metab., 2002, vol. 87, pp. 1300—1308.
28. Hattori N., Saito T., Yagyu T. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T-cells, B-cells, and neutrophils. J. Clin. Endocrinol. Metab., 2001, vol. 86, pp. 4284—4291.
29. Qader S.S., Lundquist I., Ekelund M. Ghrelin activates neuronal constitutive nitric oxide synthase in pancreatic islet cells while inhibiting insulin release and stimulating glucagon release. Regul. Pept., 2005, vol. 128, pp. 51—56.
30. Korbonits M., Goldstone A.P., Gueorguiev M. Ghrelin — a hormone with multiple functions. Front. Neuroendocrinol., 2004, vol. 25, no. 1, pp. 27—68.
31. Broglio F., Arvat E., Benso A. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J. Clin. Endocrinol. Metab., 2001, vol. 86, pp. 5083—5086.
32. Baldanzi G., Filigheddu N., Cutrupi S. Ghrelin and desacyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J. Cell. Biol., 2002, vol. 159, pp. 1029—1037.
33. Fuglsang J., Skjaebaek C., Espelund U. Ghrelin and its relationship to growth hormones during normal pregnancy. Clin. Endocrinol. (Oxf.), 2005, vol. 62, no. 5, pp. 554—559.
34. Lee H.M., Wang G., Englander E.W. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinol., 2002, vol. 143,
pp. 185—190.
35. Date Y., Kojima M., Hosoda H. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinol., 2000, vol. 141, pp. 4255—4261.
36. Gualillo O., Caminos J., Blanco M. Ghrelin, a novel placental-derived hormone. Endocrinol., 2001, vol. 142, pp. 788—794.
37. Gualillo O., Lago F., Gómez-Reino J. Ghrelin, a widespread hormone: insights into molecular and cellular regulation of its expression and mechanism of action. FEBS Letters, 2003, vol. 552, no. 2—3, pp. 105—109.
38. Prado C.L., Pugh-Bernard A.E., Elghazi L. Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. Proc. Natl. Acad. Sci., USA, 2004, vol. 101, pp. 2924—2929.
39. Chuang J.C., Sakata I., Kohno D. Ghrelin directly stimulates glucagon secretion from pancreatic α-cells. Mol. Endocrinol., 2011, vol. 25, pp. 1600—1611.
40. Kojima M., Hosoda H., Matsuo H. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol. Metab., 2001, vol. 12, pp. 118—122.
41. esauro M., Schinzari F., Iantorno M. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation, 2005, vol. 112, no. 19, pp. 2986—2992.
42. Dixit V.D., Schaffer E.M., Pyle Ghrelin R.S. Inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J. Clin. Invest., 2004, vol. 114, no. 1, pp. 57—66.
43. Kojima M., Hosoda H., Date Y. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 1999, vol. 402, pp. 656—660.
44. Wierup N., Yang S., McEvilly R.J. Ghrelin is expressed in a novel endocrine cell type in developing rat islets and inhibits insulin secretion from INS-1 (832/13) cells. J. Hystochem. Cytochem., 2004, vol. 52, no. 3, pp. 301—310.
45. Ghrelin is present in pancreatic α-cells of humans and rats and stimulates insulin secretion / [et al.] // Diabetes. — 2002. — V. 51. — P. 124—129.
46. Date Y., Nakazato M., Hashiguchi S. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J. Biol. Chem., 2002, vol. 277, pp. 5667—5674.
47. Trudel L., Tomasetto C., Rio M.C. Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. Am. J. Physiol. Gastrointest. Liver Physiol., 2002, vol. 282, pp. G948—G952.
48. Andralojc K.M., Mercalli A., Nowak K.W. Ghrelin-producing epsilon cells in the developing and adult human pancreas. Diabetol., 2009, vol. 52, is. 3, pp. 486—493.
49. Masuda Y., Tanaka T., Inomata M. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem. Biophys. Res. Commun., 2000, vol. 276,
pp. 905—908.
50. Dornonville De La Cour C., Lindstrom E., Norlen P. Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells. Regul. Pept., 2004, vol. 120, pp. 23—32.
51. Takaya K., Ariyasu H., Kanamoto N. Ghrelin strongly stimulates growth hormone release in humans. J. Clin. Endocrinol. Metab., 2000, vol. 85, pp. 4908—4911.
52. Ghelardoni S., Carnicelli V., Frascarelli S. Ghrelin tissue distribution: comparison between gene and protein expression. J. Endocrinol. Invest., 2006, vol. 29, no. 2, pp. 115—121.
53. Granata R., Ghigo E. Products of the ghrelin gene, the pancreatic β-cell and the adipocyte. The Ghrelin System. Basel, Karger, 2013, vol. 25, Endocrine Development, pp. 144—156.
54. Papotti M., Ghè C., Cassoni P. Growth hormone secretagogue binding sites in peripheral human tissues. J. Clin. Endocrinol. Metab., 2000, vol. 85,
pp. 3803—3807.
55. Nagaya N., Kojima M., Uematsu M. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am. J. Physiol. Regul. Integr. Physiol., 2001, vol. 280, no. 5, pp. 1483—1487.
56. Nagaya N., Miyatake K., Uematsu V.J. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. J. Clin. Endocrinol. Metab., 2001, vol. 86, pp. 5854—5859.
57. Heppner K.M., Tong J. Mechanisms in endocrinology: regulation of glucose metabolism by the ghrelin system: multiple players and multiple actions. Eur. J. Endocrinol., 2014, vol. 171, no. 1, pp. R21— R32.
58. Hosoda H., Kojima M., Kangawa K. Ghrelin and the regulation of food intake and energy balance. Mol. Intervent., 2002, vol. 2, no. 8, pp. 494—503.
59. Faulconbridge L.F., Cummings D.E., Kaplan J.M. Hyperphagic effects of brainstem ghrelin administration. Diabetes, 2003, vol. 52, pp. 2260—2265.
60. Bennett N.R., Boyne M.S., Cooper R.S. Impact of adiponectin and ghrelin on incident glucose intolerance and on weight change. Clin. Endocrinol., 2009, vol. 70, no. 3, pp. 408—414.
61. Egido E.M., Rodriguez-Gallardo J., Silvestre R.A. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur. J. Endocrinol., 2002, vol. 146, no. 2, pp. 241—244.
62. Murdolo G., Lucidi P., Di Loreto C. Insulin is required for prandial ghrelin suppression in humans. Diabetes, 2003, vol. 52, no. 12, pp. 2923—2927.
63. Saad M.F., Bernaba B., Hwu C.-M. Insulin regulates plasma ghrelin concentration. J. Clin. Endocrinol. Metab., 2002, vol. 87, pp. 3997—4000.
64. Isgaard J. Ghrelin and the cardiovascular system. The Ghrelin System. Basel, Karger, 2013, vol. 25, Endocrine Development, pp. 83—90.
65. Isgaard J., Granata R. Ghrelin in cardiovascular disease and atherogenesis. Mol. Cell. Endocrinol., 2011, vol. 340, no. 1, pp. 59—64.
66. Mori K., Yoshimoto A., Takaya K. Kidney produces a novel acylated peptide, ghrelin., FEBS Lett., 2000, vol. 486, no. 3, pp. 213—216.
67. Kojima М., Kangawa К. Ghrelin discovery: a decade after. The Ghrelin System. Basel, Karger, 2013, vol. 25, Endocrine Development, pp. 1—4.
68. Kojima M., Kangawa K. Ghrelin. Structure and function. Physiol. Rev., 2005, vol. 85, no. 2, pp. 495—522.
69. Pöykkö S.M., Kellokoski E., Hörkkö S. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes, 2003, vol. 52, no. 10, pp. 2546—2553.
70. Mendes-Sanches N., Ponciano-Rodrigues G., Bermegjo-Martines L. Low serum levels of ghrelin are assosiated with gallstone disease. World J. Gastroenterol., 2006, vol. 12, no. 19, pp. 3096—3100.
71. Meier U., Gressner A.M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin. Chem., 2004, vol. 50, pp. 1511—1525.
72. Tesauro M., Schinzari F., Caramanti M. Metabolic and cardiovascular effects of ghrelin. Inter. J. Pept., 2010, vol. 2010, art. ID 864342, 7 p. Available at: http://dx.doi.org/10.1155/2010/864342 (accessed: 12 October 2014).
73. Park S., Jiang H., Zhang H. Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release. PNAS, 2012, vol. 109, pp. 19003—19008.
74. Kageyama H., Funahashi H., Hirayama M. Morphological analysis of ghrelin and its receptor distribution in the rat pancreas. Regul. Pept., 2005, vol. 126, pp. 67—71.
75. Nagaya N., Kangawa K. Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure. Regul. Pept., 2003, vol. 114,
pp. 71—77.
76. Pettersson I., Muccioli G., Granata R. Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2 cardiomyocyte cell proliferation. J. Endocrinol., 2002, vol. 175, pp. 201—209.
77. Muccioli G., Tshop M., Papotti M. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur. J. Pharmacol., 2002, vol. 440, pp. 235—254.
78. Liu J., Prudom C.E., Nass R. Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men. J. Clin. Endocrinol. Metab., 2008, vol. 93, pp. 1980—1987.
79. Shiiya T., Nakazato M., Mizuta M. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J. Clin. Endocrinol. Metab., 2002, vol. 87, no. 1, pp. 240—244.
80. Soule S., Pemberton C., Hunt P. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin? Clin. Endocrinol. (Oxf.), 2005, vol. 63, pp. 412—417.
81. Qader S.S., Hakanson R., Rehfeld J.F. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas. Regul. Pept., 2008, vol. 146, pp. 230—237.
82. Reimer M.K., Pacini G., Ahren B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinol., 2003, vol. 144, pp. 916—921.
83. Arosio M., Ronchi C.L., Gebbia C. Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels. J. Clin. Endocrinol. Metab., 2003, vol. 88, pp. 701—704.
84. Sato T., Nakamura Y., Shiimura Y. Structure, regulation and function of ghrelin. J. Biochem., 2012, vol. 151, is. 2, pp. 119—128.
85. Tena-Sempere M. Roles of ghrelin and leptin in the control of reproductive Function. Neuroendocrinol., 2007, vol. 86, pp. 229—241.
86. Wierup N., Svensson H., Mulder H. The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul. Pept., 2002, vol. 10,
pp. 763—769.
87. Wren A.M., Small C.J., Ward H.L. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinol., 2000, vol. 141, pp. 4325—4328.
88. Gnanapavan S., Kola B., Bustin S.A. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab., 2002, vol. 87, pp. 2988—2991.
89. Cabrera O., Berman D.M., Kenyon N.S. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc. Natl. Acad. Sci., USA, 2006, vol. 103, pp. 2334—2339.
90. Thorens B. Brain glucose sensing and neural regulation of insulin and glucagon secretion. Diabetes Obesity Metab., 2011, vol. 13, pp. 82—88.
91. Tschop M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature, 2000, vol. 407, pp. 908—913.
92. Okumura E.L., Nagaya N., Enomoto M. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J. Cardiovasc. Pharmacol., 2002, vol. 39, no. 6, pp. 779—783.
93. Wierup N., Sundler F., Heller R.S. The islet ghrelin cell. J. Mol. Endocrinol., 2014, vol. 52, no. 1, pp. R35—R49.
94. Wu J.T., Kral J.G. Ghrelin: integrative neuroendocrine peptide in health and disease. Ann. Surg., 2004, vol. 239, pp. 464—474.